Royal Bank of Canada
OLMA icon

Royal Bank of Canada’s Olema Pharmaceuticals OLMA Stock Holding History

Royal Bank of Canada’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15K Sell
1,000
-5,700
-85% -$127K ﹤0.01% 6017
2025
Q4 		$167K Sell
6,700
-141,637
-95% -$2.52M ﹤0.01% 4890
2025
Q3 		$1.45M Buy
148,337
+30,533
+26% +$183K ﹤0.01% 3672
2025
Q2 		$501K Buy
117,804
+95,865
+437% +$427K ﹤0.01% 4464
2025
Q1 		$83K Sell
21,939
-1,179
-5% -$5.93K ﹤0.01% 5329
2024
Q4 		$135K Sell
23,118
-485
-2% -$4.84K ﹤0.01% 5140
2024
Q3 		$282K Buy
23,603
+10,972
+87% +$140K ﹤0.01% 4556
2024
Q2 		$137K Buy
12,631
+12,012
+1,941% +$130K ﹤0.01% 5060
2024
Q1 		$7K Sell
619
-7,526
-92% -$97.1K ﹤0.01% 6344
2023
Q4 		$114K Buy
8,145
+3,637
+81% +$48.9K ﹤0.01% 5538
2023
Q3 		$56K Buy
4,508
+1,707
+61% +$17.4K ﹤0.01% 5717
2023
Q2 		$25K Buy
2,801
+2,443
+682% +$14.8K ﹤0.01% 6096
2023
Q1 		$1K Buy
358
+276
+337% +$1.13K ﹤0.01% 6916
2022
Q4 		$0 Buy
82
+8
+11% +$23 ﹤0.01% 7573
2022
Q3 		$0 Buy
+74
New +$314 ﹤0.01% 7720
2022
Q2 		– Sell
-1,576
Closed -$7K – 7607
2022
Q1 		$7K Sell
1,576
-118,111
-99% -$651K ﹤0.01% 7117
2021
Q4 		$1.12M Buy
119,687
+117,098
+4,523% +$2.43M ﹤0.01% 3689
2021
Q3 		$71K Buy
2,589
+1,190
+85% +$32.1K ﹤0.01% 5949
2021
Q2 		$39K Buy
1,399
+298
+27% +$8.48K ﹤0.01% 6204
2021
Q1 		$37K Buy
+1,101
New +$47.2K ﹤0.01% 6073

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Royal Bank of Canada's OLMA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Olema Pharmaceuticals (OLMA) stake by 85% in Q1 2026, selling an estimated $127K and leaving 1,000 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #6017.

Royal Bank of Canada first reported a position in OLMA in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.45M in Q3 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Royal Bank of Canada held 1,000 shares of Olema Pharmaceuticals worth $15K as of Q1 2026.
  • Royal Bank of Canada sold 5,700 Olema Pharmaceuticals shares in Q1 2026, an estimated $127K.
  • Olema Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6017 holding.
  • Royal Bank of Canada first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 20 quarters since.
  • Royal Bank of Canada's Olema Pharmaceuticals position peaked at $1.45M in Q3 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.